Nemaura Medical Inc. (NMRD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 9.92 Million USD | 589.48% |
| 2022 | 1.43 Million USD | 120.73% |
| 2021 | -6.94 Million USD | -6443.66% |
| 2020 | -106.1 Thousand USD | 97.16% |
| 2019 | -3.74 Million USD | -354.88% |
| 2018 | -822.33 Thousand USD | 9.77% |
| 2017 | -911.35 Thousand USD | 90.31% |
| 2016 | -9.4 Million USD | -2550.88% |
| 2015 | -354.74 Thousand USD | 81.06% |
| 2014 | -1.87 Million USD | -834.3% |
| 2013 | -200.48 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 13.07 Million USD | 31.76% |
| 2024 Q3 | 19.5 Million USD | -0.14% |
| 2024 Q2 | 19.53 Million USD | 49.37% |
| 2023 FY | 9.92 Million USD | 589.48% |
| 2023 Q3 | 12.72 Million USD | 18.09% |
| 2023 Q1 | 6.13 Million USD | 326.14% |
| 2023 Q4 | 9.92 Million USD | -22.03% |
| 2023 Q2 | 10.77 Million USD | 75.73% |
| 2022 Q1 | -6.09 Million USD | 12.27% |
| 2022 Q4 | 1.43 Million USD | 178.15% |
| 2022 FY | 1.43 Million USD | 120.73% |
| 2022 Q3 | 517.51 Thousand USD | 124.14% |
| 2022 Q2 | -2.14 Million USD | 64.81% |
| 2021 Q3 | -9.65 Million USD | 17.73% |
| 2021 Q4 | -6.94 Million USD | 28.06% |
| 2021 Q1 | -1.16 Million USD | -4864.0% |
| 2021 Q2 | -11.73 Million USD | -903.66% |
| 2021 FY | -6.94 Million USD | -6443.66% |
| 2020 FY | -106.1 Thousand USD | 97.16% |
| 2020 Q4 | -23.54 Thousand USD | 97.56% |
| 2020 Q1 | -3.06 Million USD | 17.97% |
| 2020 Q2 | -1.77 Million USD | 42.28% |
| 2020 Q3 | -963.52 Thousand USD | 45.6% |
| 2019 Q3 | -5.04 Million USD | -858.03% |
| 2019 Q4 | -3.74 Million USD | 25.79% |
| 2019 Q1 | -319.99 Thousand USD | 61.09% |
| 2019 Q2 | -526.14 Thousand USD | -64.43% |
| 2019 FY | -3.74 Million USD | -354.88% |
| 2018 Q1 | -1.28 Million USD | -40.94% |
| 2018 Q2 | -597.53 Thousand USD | 53.48% |
| 2018 Q3 | -1.66 Million USD | -178.58% |
| 2018 Q4 | -822.33 Thousand USD | 50.6% |
| 2018 FY | -822.33 Thousand USD | 9.77% |
| 2017 Q4 | -911.35 Thousand USD | 88.0% |
| 2017 FY | -911.35 Thousand USD | 90.31% |
| 2017 Q3 | -7.59 Million USD | 8.71% |
| 2017 Q2 | -8.31 Million USD | 2.07% |
| 2017 Q1 | -8.49 Million USD | 9.67% |
| 2016 Q4 | -9.4 Million USD | 4.54% |
| 2016 Q2 | -99.82 Thousand USD | 20.67% |
| 2016 Q3 | -9.85 Million USD | -9769.07% |
| 2016 Q1 | -125.83 Thousand USD | 64.53% |
| 2016 FY | -9.4 Million USD | -2550.88% |
| 2015 Q2 | -907.3 Thousand USD | 18.39% |
| 2015 FY | -354.74 Thousand USD | 81.06% |
| 2015 Q3 | -613.6 Thousand USD | 32.37% |
| 2015 Q4 | -354.74 Thousand USD | 42.19% |
| 2015 Q1 | -1.11 Million USD | 40.65% |
| 2014 Q3 | -6826.00 USD | 0.0% |
| 2014 Q1 | 200.48 Thousand USD | 200.0% |
| 2014 Q4 | -1.87 Million USD | -27341.27% |
| 2014 FY | -1.87 Million USD | -834.3% |
| 2013 FY | -200.48 Thousand USD | 0.0% |
| 2013 Q4 | -200.48 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 63.352% |
| BrainsWay Ltd. | -10.32 Million USD | 196.173% |
| Cerus Corporation | 84.35 Million USD | 88.234% |
| Envoy Medical, Inc. | -3.81 Million USD | 360.226% |
| electroCore, Inc. | -9.95 Million USD | 199.699% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 293.659% |
| IceCure Medical Ltd | -9.93 Million USD | 199.91% |
| Inogen, Inc. | -103.56 Million USD | 109.583% |
| OrthoPediatrics Corp. | -9.26 Million USD | 207.101% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 372.59% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 175.781% |
| MaxCyte, Inc. | -27.76 Million USD | 135.749% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 293.165% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1823.79% |
| Orthofix Medical Inc. | 96.44 Million USD | 89.709% |
| PAVmed Inc | 29.08 Million USD | 65.877% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 158.593% |
| RxSight, Inc. | -6.68 Million USD | 248.578% |
| Sight Sciences, Inc. | -102.71 Million USD | 109.663% |
| SI-BONE, Inc. | 5.72 Million USD | -73.484% |
| TELA Bio, Inc. | -3.94 Million USD | 351.33% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 82.685% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -2719.607% |
| Acutus Medical, Inc. | 12.27 Million USD | 19.171% |
| Talis Biomedical Corporation | -57.06 Million USD | 117.393% |
| Spectral AI, Inc. | -3.5 Million USD | 383.491% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 120.665% |
| CVRx, Inc. | -59.95 Million USD | 116.554% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -400.216% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -676.826% |
| Bioventus Inc. | 372.51 Million USD | 97.336% |
| Venus Concept Inc. | 74.3 Million USD | 86.642% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 197.476% |
| LivaNova PLC | 62.53 Million USD | 84.128% |
| 908 Devices Inc. | -115.09 Million USD | 108.623% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 96.905% |
| NeuroPace, Inc. | 54.33 Million USD | 81.734% |
| LENSAR, Inc. | -18.31 Million USD | 154.2% |
| Apyx Medical Corporation | -5.15 Million USD | 292.681% |
| Cutera, Inc. | 288.3 Million USD | 96.557% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -32.069% |
| BioSig Technologies, Inc. | 262 Thousand USD | -3688.174% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 122.644% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 207.892% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.294% |
| Axonics, Inc. | -77.19 Million USD | 112.857% |
| Outset Medical, Inc. | 67.67 Million USD | 85.335% |
| IRIDEX Corporation | -4.28 Million USD | 331.46% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 105.575% |
| IRadimed Corporation | -47.71 Million USD | 120.799% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 427.991% |
| INVO Bioscience, Inc. | 8.45 Million USD | -17.44% |
| Telesis Bio, Inc. | 32.63 Million USD | 69.588% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 496.662% |
| Varex Imaging Corporation | 316.9 Million USD | 96.868% |
| Quipt Home Medical Corp. | 81.73 Million USD | 87.857% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 456.758% |
| Pulmonx Corporation | -42.36 Million USD | 123.43% |
| Dynatronics Corporation | 6.2 Million USD | -59.977% |
| Modular Medical, Inc. | -8.04 Million USD | 223.415% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 330.975% |
| Semler Scientific, Inc. | -57.13 Million USD | 117.373% |
| InMode Ltd. | -135.39 Million USD | 107.33% |
| Bruker Corporation | 891.3 Million USD | 98.886% |
| Cytosorbents Corporation | 4.18 Million USD | -137.326% |
| DexCom, Inc. | 2.02 Billion USD | 99.511% |
| Align Technology, Inc. | -840.47 Million USD | 101.181% |
| Viveve Medical, Inc. | -13.81 Million USD | 171.853% |
| ZimVie Inc. | 450.41 Million USD | 97.796% |
| Movano Inc. | -5.86 Million USD | 269.196% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 107.382% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1823.79% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -400.216% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 97.218% |
| Profound Medical Corp. | -18.17 Million USD | 154.598% |
| Insulet Corporation | 798.1 Million USD | 98.756% |
| enVVeno Medical Corporation | -2.21 Million USD | 547.476% |
| Surmodics, Inc. | -12.01 Million USD | 182.612% |
| iCAD, Inc. | -21.2 Million USD | 146.796% |
| Nuwellis, Inc. | -2.81 Million USD | 452.076% |
| Biotricity, Inc. | 23.09 Million USD | 57.021% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 89.402% |
| Aethlon Medical, Inc. | -4.5 Million USD | 320.474% |
| InspireMD, Inc. | -8.04 Million USD | 223.369% |
| PAVmed Inc. | 29.08 Million USD | 65.877% |
| BIOLASE, Inc. | 11.34 Million USD | 12.509% |
| Beyond Air, Inc. | 6.22 Million USD | -59.336% |
| FONAR Corporation | -14.66 Million USD | 167.677% |
| AxoGen, Inc. | 32.26 Million USD | 69.24% |
| Vivani Medical, Inc. | 42 Thousand USD | -23530.99% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 193.123% |
| Inari Medical, Inc. | -7.16 Million USD | 238.598% |
| UFP Technologies, Inc. | 40.77 Million USD | 75.658% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -223.435% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 308.014% |
| Tenon Medical, Inc. | -1.25 Million USD | 890.838% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 230.489% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 183.219% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.552% |
| Sintx Technologies, Inc. | 905 Thousand USD | -996.687% |
| NanoVibronix, Inc. | -3.27 Million USD | 402.777% |
| Quanterix Corporation | -132.95 Million USD | 107.465% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 456.758% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 144.377% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 98.683% |
| TransMedics Group, Inc. | 121.13 Million USD | 91.807% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 137.911% |
| NeuroMetrix, Inc. | -1.49 Million USD | 765.63% |
| Hyperfine, Inc. | -75.61 Million USD | 113.125% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 93.478% |
| Biomerica, Inc. | -3.38 Million USD | 393.206% |
| Bone Biologics Corporation | -3.02 Million USD | 427.93% |
| AVITA Medical, Inc. | -26.23 Million USD | 137.836% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 639.869% |
| Silk Road Medical, Inc | 64.42 Million USD | 84.594% |